03411nas a2200313 4500000000100000008004100001260003700042653001200079653001300091653002600104653001800130653000900148653001100157653001600168100001800184700001400202700001800216700001800234700001400252700001600266700001200282700001500294245007200309856009900381300000900480490000700489520258700496022001403083 2025 d bPublic Library of Science (PLoS)10aLeprosy10aSkeleton10aMycobacterium leprae 10apaleogenetics10aBone10aEurope10aArchaeology1 aAborghetti HP1 aCollin SM1 ados Santos JD1 ados Santos PB1 aZambon TL1 aLoureiro RM1 aDeps PD1 aRöltgen K00aLeprosy in skeletons from archaeological sites: A systematic review uhttps://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0013374&type=printable a1-230 v193 a

Background

Leprosy (Hansen’s disease) is an ancient stigmatising infectious disease that remains endemic in many countries. Leprosy-related bone changes that cause disabilities in affected persons are evident in skeletons from archaeological sites. The aim of our synthesis of paleopathological data was to gain insights into the disease’s historical distribution and presentation.

Methodology

Systematic review of paleopathological studies describing human remains with signs of leprosy published up to December 2023. Extracted data on bone features from skulls and limbs, including rhinomaxillary syndrome (RMS) in cranial bones and post-cranial bone changes (PCBC) in hands and feet, were summarised, together with genomic data from studies of Mycobacterium leprae ancient DNA.

Findings

The 297 skeletons described in 67 studies comprised 264 skeletons from sites in modern-day Europe (117 from England, 68 from Denmark); 23 skeletons from Asia (10 from India), 5 from The Americas, and 4 from the African continent (all from Egypt); 174 (58.6%) were from leprosaria, 255 (85.9%) were adults, 28 (9.4%) adolescent, 14 (4.7%) of indeterminate age. Skeletons dated from 3715 BCE to 1839 CE, peaking around the 15th Century. Probable and possible RMS were identified in 85 (30.5%) and 153 (54.8%) of 279 skeletons with cranial data, respectively. Lower limb pathological PCBC were most prevalent in tarsals (76.6%), metatarsals (81.5%), and feet phalanges (85.6%). In upper limbs, 75.8% of humeri, 65.8% of radii, 61.0% of ulnae and 75.8% of hand phalanges exhibited pathological alterations. From 73 skeletons from 19 genomic studies, M. leprae single nucleotide polymorphism (SNP) type 3 was identified in 59 skeletons (80.8%), SNP type 2 in 11 (15.1%), type 4 in two, and type 1 in one.

Conclusions

Four out of five archaeological skeletons with leprosy exhibited some degree of RMS, which is pathognomonic of the most severe form of the disease, irrespective of whether the skeleton was excavated from a leprosarium (leprosy hospital) or from a public cemetery or other burial site. The relatively small numbers of remains excavated over a wide geographical area and a long time period, and the focus of archaeological studies on skeletons already identified as having leprosy, mean that it is difficult to prove or disprove theories that aim to explain the decline and eventual disappearance of leprosy as a disease in Europe.

 a1935-2735